Clinical Trial Update: Novel MRI Biomarkers for Monitoring Disease Progression in ALS

View source ↗

Summary

University of Alberta is recruiting for a clinical study evaluating novel MRI biomarkers to monitor disease progression in amyotrophic lateral sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Motor Neuron Disease

Snippet

Sponsor: University of Alberta | Conditions: Amyotrophic Lateral Sclerosis, Motor Neuron Disease | Status: RECRUITING